Ultragenyx Pharmaceutical Inc (RARE)
46.61
+0.21
(+0.45%)
USD |
NASDAQ |
Nov 21, 15:16
Ultragenyx Pharmaceutical Price to Book Value: 12.41 for Nov. 21, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 20, 2024 | 12.35 |
| November 19, 2024 | 12.02 |
| November 18, 2024 | 11.66 |
| November 15, 2024 | 11.91 |
| November 14, 2024 | 12.68 |
| November 13, 2024 | 12.97 |
| November 12, 2024 | 12.74 |
| November 11, 2024 | 13.51 |
| November 08, 2024 | 13.41 |
| November 07, 2024 | 13.43 |
| November 06, 2024 | 13.45 |
| November 05, 2024 | 13.89 |
| November 04, 2024 | 13.60 |
| November 01, 2024 | 13.58 |
| October 31, 2024 | 13.58 |
| October 30, 2024 | 13.80 |
| October 29, 2024 | 14.05 |
| October 28, 2024 | 14.12 |
| October 25, 2024 | 14.32 |
| October 24, 2024 | 14.59 |
| October 23, 2024 | 14.56 |
| October 22, 2024 | 14.58 |
| October 21, 2024 | 14.49 |
| October 18, 2024 | 14.97 |
| October 17, 2024 | 15.11 |
| Date | Value |
|---|---|
| October 16, 2024 | 15.36 |
| October 15, 2024 | 15.20 |
| October 14, 2024 | 14.95 |
| October 11, 2024 | 14.66 |
| October 10, 2024 | 14.34 |
| October 09, 2024 | 14.21 |
| October 08, 2024 | 14.19 |
| October 07, 2024 | 13.95 |
| October 04, 2024 | 14.32 |
| October 03, 2024 | 14.28 |
| October 02, 2024 | 14.78 |
| October 01, 2024 | 15.04 |
| September 30, 2024 | 14.78 |
| September 27, 2024 | 11.60 |
| September 26, 2024 | 11.77 |
| September 25, 2024 | 12.10 |
| September 24, 2024 | 12.25 |
| September 23, 2024 | 12.27 |
| September 20, 2024 | 12.52 |
| September 19, 2024 | 12.53 |
| September 18, 2024 | 12.30 |
| September 17, 2024 | 12.47 |
| September 16, 2024 | 12.65 |
| September 13, 2024 | 12.52 |
| September 12, 2024 | 12.33 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
2.993
Minimum
Mar 16 2020
127.36
Maximum
Dec 27 2023
14.09
Average
7.281
Median
Mar 31 2021
Price to Book Value Benchmarks
| Alnylam Pharmaceuticals Inc | 978.62 |
| NovaBay Pharmaceuticals Inc | 3.121 |
| Palatin Technologies Inc | -- |
| iBio Inc | 1.237 |
| Theriva Biologics Inc | 0.1400 |
Price to Book Value Related Metrics
| PS Ratio | 7.748 |
| Price | 46.61 |
| Earnings Yield | -13.88% |
| Market Cap | 4.304B |